Funded Tech Companies
Glympse Bio
Wondering who backed Glympse Bio? Temasek Holdings, New Leaf Venture Partners and Catalio Capital Management joined the equity holders in this biopharmaceutical company.
Company Overview
Company Name
Glympse Bio
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
35 Cambridgepark Dr. 100
Cambridge, MA 02140
USA
Cambridge, MA 02140
USA
Phone
Website
Email Address
Company Background Information
Overview
Glympse Bio is pioneering an in vivo sensing technology dedicated to transforming disease monitoring. The company has built a product engine enabling rapid development of tunable and bioengineered activity sensors for multiple indications including fibrosis, cancer, immunology and infectious diseases.
Last Transaction
7/17/2020
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Company Investors
- Temasek Holdings (Cayce Denton)
- New Leaf Venture Partners
- Catalio Capital Management
- Polaris Partners (Amy Schulman)
- CRV
- Section 32 (Steven Kafka)
- Waterman Ventures
- Arch Venture Partners
- Gilead Sciences
- Greatpoint Ventures Innovation Fund
- DNS Capital
- Heritage Provider Network
- Rivas Capital
- Inevitable Ventures
- Yonghua Capital
Browse more funded tech companies:
Share this article
About Our VC Funding Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs